CinCor Pharma Accounts Payable

CinCor Pharma posts a accounts payable of $2.6M as of September 2022. That compares with $4M in the prior-year period — down 35.4% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, CinCor Pharma's accounts payable was $4M. The latest reading is $2.6M — a 35.4% year-over-year decrease (period ending September 2022). Use the history and growth charts on this page for a longer lookback.

Accounts Payable is one piece of CinCor Pharma's financial statement story. At $2.6M, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for CINC's accounts payable usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; CinCor Pharma's other metric pages and overview cover the third.